Denying Abbott proposal DTAB rules Zolpidem continues to be Schedule H1 drug Dr. Divya Colin25 Oct 2022 11:30 AM ISTNew Delhi: Denying the pharma major Abbott India proposal to change schedule of Zolpidem Tartrate from Schedule H1 to Schedule H of the Drugs Rules,...
Abbott launches Amplatzer Talisman PFO Occlusion System in Europe to close hole in heart for people at risk of recurrent stroke Ruchika Sharma9 Sept 2022 9:00 AM ISTAbbott Park, Ill.: Abbott has announced the European launch of its Amplatzer Talisman PFO Occlusion System to treat people with a patent...
Indian Pharma Market sees 12.1 percent growth in August: AIOCD-AWACS Report Farhat Nasim7 Sept 2022 5:53 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) saw significant growth of 12.1 percent in value and 4.8 percent in volume, in the month of August,...
Abbott restarts Similac infant formula production at Michigan facility Kajal Rajput29 Aug 2022 2:46 PM ISTChicago : Abbott Laboratories has restarted production of its Similac infant formula at the plant in Sturgis, Michigan at the center of the U.S. baby...
Abbott gets USFDA nod for new Proclaim Plus spinal cord stimulation device Ruchika Sharma26 Aug 2022 3:01 PM ISTBurstDR therapy is Abbott's exclusive stimulation technology that delivers pulses – or bursts – of mild electrical energy to alter pain signals as...
Indian Pharma Market Sees 14.1 Percent Growth In July Sales: AIOCD-AWACS Report Susmita Roy7 Aug 2022 11:29 AM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has witnessed a significant growth of 14.1% in value and 7.3% in volume in the month of July across...
Abbott gets USFDA breakthrough device designation for deep brain stimulation system in depression Ruchika Sharma14 July 2022 5:27 PM ISTAbbott's DBS system is a personalized, adjustable therapy that involves implanting thin wires – or leads – into targeted areas of the brain.
Baby formula production resumes at Abbott Nutrition factory in Michigan Ruchika Sharma11 July 2022 2:00 PM IST"We are working to restart Similac production as soon as we can. We'll provide more information when we have it," Abbott spokesman John Koval said via...
Abbott Healthcare faces 5 year ban from Tamil Nadu Govt agency: Report Farhat Nasim9 Jun 2022 11:00 AM ISTChennai: Coming down heavily on Abbott Healthcare, the Tamil Nadu Medical Services Corporation (TNMSC) has placed the company on 5-year ban list for...
FDA clears freeStyle Libre 3 system for use by people aged 4 years and older living with diabetes Meghna A Singhania3 Jun 2022 10:30 AM ISTABBOTT PARK, Ill: The US FDA has granted clearance clearance to FreeStyle Libre 3 system from Abbott for use by people aged 4 years and older living...
Abbott labs India unit concludes recall of baby formula products manufactured at Michigan facility Ruchika Sharma21 May 2022 11:51 AM ISTSimilac supplied in India is produced at Abbott's plant in the country's western state of Gujarat.
Drug alert: CDSCO flags 27 medicine batches as not of standard quality Ruchika Sharma14 May 2022 2:48 PM ISTNew Delhi: In its latest drug safety alert, the Central Drugs Standard Control Organization (CDSCO) has flagged 27 medicine batches as not of Standard...
